Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Simon Fraser University

$25,000.00

A novel approach to treating salmonella infection in poultry

EF 2013-14

Résumé
Salmonella infections represent a significant public health concern and disease burden. A significant source ofinfections are typically contaminated meat and poultry, eggs, and fresh produce. As such, the control ofSalmonella infections in poultry products is one means to reduce human infections. While advances have beenmade in reducing the frequency of Salmonella contamination in processed poultry, there is mounting pressureon commercial growers to prevent and/or eliminate these pathogens in pre-harvest production facilities. Theresult of this key initial work will be the identification of new targets for a novel antibody-based therapeuticstrategy that may be provided to commercial growers to prevent and/or eliminate Salmonella pathogens inpre-harvest poultry production facilities. This work capitalizes on the bioinformatics expertise andcomputational resources of the Brinkman Laboratory, coupled with their level 2 molecular microbiology labcapabilities, and complements well the expertise of the larger research team, including the antibodydevelopment platform offered by Novobind Livestock Therapeutics Inc. This project proposes to:(1) use advanced genomics and bioinformatics analyses to identify, categorize and prioritize cell surface orsecreted, soluble targets that are known to be essential and cause virulence in Salmonella typhimurium andSalmonella enterica for an antibody-based therapeutic to be developed in collaboration with NovoBind.(2) purify protein for the most promising 2-4 targets, for subsequent antibody generation in collaboration withthe larger project team.The development of a Salmonella-selective and highly effective antibody, based on the antigen selectionperformed in our lab, would benefit Canadian and World populations by reducing human infection and illness,loss of life and costs of treatment. The revenue generated by NovoBind in delivering this product would also bean economic boost to Canada.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
453524-2013
Name nom
Brinkman, Fiona
Department département
Molecular Biology and Biochemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
A novel approach to treating salmonella infection in poultry
Keyword
NSERC
Application summary
Salmonella infections represent a significant public health concern and disease burden. A significant source ofinfections are typically contaminated meat and poultry, eggs, and fresh produce. As such, the control ofSalmonella infections in poultry products is one means to reduce human infections. While advances have beenmade in reducing the frequency of Salmonella contamination in processed poultry, there is mounting pressureon commercial growers to prevent and/or eliminate these pathogens in pre-harvest production facilities. Theresult of this key initial work will be the identification of new targets for a novel antibody-based therapeuticstrategy that may be provided to commercial growers to prevent and/or eliminate Salmonella pathogens inpre-harvest poultry production facilities. This work capitalizes on the bioinformatics expertise andcomputational resources of the Brinkman Laboratory, coupled with their level 2 molecular microbiology labcapabilities, and complements well the expertise of the larger research team, including the antibodydevelopment platform offered by Novobind Livestock Therapeutics Inc. This project proposes to:(1) use advanced genomics and bioinformatics analyses to identify, categorize and prioritize cell surface orsecreted, soluble targets that are known to be essential and cause virulence in Salmonella typhimurium andSalmonella enterica for an antibody-based therapeutic to be developed in collaboration with NovoBind.(2) purify protein for the most promising 2-4 targets, for subsequent antibody generation in collaboration withthe larger project team.The development of a Salmonella-selective and highly effective antibody, based on the antigen selectionperformed in our lab, would benefit Canadian and World populations by reducing human infection and illness,loss of life and costs of treatment. The revenue generated by NovoBind in delivering this product would also bean economic boost to Canada.